Detalhe da pesquisa
1.
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
Gut
; 72(11): 2031-2038, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468228
2.
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg).
J Clin Gastroenterol
; 56(2): e98-e108, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405435
3.
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients.
Gut
; 70(1): 40-54, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958544
4.
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
Helicobacter
; 25(5): e12722, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656898
5.
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
Helicobacter
; 25(3): e12686, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173974
6.
Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection.
Gastroenterol Hepatol
; 43(3): 117-125, 2020 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31810793
7.
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Dig Dis Sci
; 64(3): 846-854, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426297
8.
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis
; 30(2): 167-182, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536268
9.
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management.
J Clin Med
; 12(13)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445399
10.
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.
J Clin Med
; 11(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233844
11.
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
J Clin Med
; 10(13)2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209680
12.
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.
J Crohns Colitis
; 15(11): 1846-1851, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860795
13.
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.
J Crohns Colitis
; 15(1): 35-42, 2021 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969471
14.
European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain.
Antibiotics (Basel)
; 10(1)2020 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375717
15.
Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
Aliment Pharmacol Ther
; 49(4): 419-428, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30637837
16.
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Therap Adv Gastroenterol
; 12: 1756284819847034, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205485
17.
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Aliment Pharmacol Ther
; 48(8): 839-851, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281832